Sort

Search

31/12/2024 Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Girolomoni, G, Feldman, SR, Egeberg, A, Puig, L, Jung, J, Jung, H, Lee, Y. Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR). JOURNAL OF DERMATOLOGICAL TREATMENT. 2024; 35(1)DOI:10.1080/09546634.2024.2434091. PMID:39626886. IF:3.900(Q1/2D).
31/12/2024 Modelling the spatial risk of malaria through probability distribution of Anopheles maculipennis s.l. and imported cases
Taheri, S, González, MA, Ruiz-López, MJ, Magallanes, S, Delacour-Estrella, S, Lucientes, J, Bueno-Marí, R, Martínez-de la Puente, J, Bravo-Barriga, D, Frontera, E, Polina, A, Martinez-Barciela, Y, Pereira, JM, Garrido, J, Aranda, C, Marzal, A, Ruiz-Arrondo, I, Oteo, JA, Ferraguti, M, Gutíerrez-López, R, Estrada, R, Miranda, MA, Barceló, C, Morchón, R, Montalvo, T, Gangoso, L, Goiri, F, García-Pérez, AL, Ruiz, S, Fernandez-Martinez, B, Gómez-Barroso, D, Figuerola, J. Modelling the spatial risk of malaria through probability distribution of Anopheles maculipennis s.l. and imported cases. Emerging Microbes & Infections. 2024; 13(1)DOI:10.1080/22221751.2024.2343911. PMID:38618930. IF:7.500(Q1/1D).
27/12/2024 Point-of-care additive manufacturing: state of the art and adoption in Spanish hospitals during pre to post COVID-19 era
Valls-Esteve, A, García, RI, Bellmunt, A, Eguiraun, H, Jauregui, I, del Amo, C, Adell-Gomez, N, Krauel, L, Munuera, J. Point-of-care additive manufacturing: state of the art and adoption in Spanish hospitals during pre to post COVID-19 era. 3d Printing In Medicine. 2024; 10(1)DOI:10.1186/s41205-024-00244-9. PMID:39729163. IF:(Q/D).
21/12/2024 Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials
Río, P, Zubicaray, J, Navarro, S, Gálvez, E, Sánchez-Domínguez, R, Nicoletti, E, Sebastian, E, Rothe, M, Pujol, R, Bogliolo, M, John-Neek, P, Bastone, AL, Schambach, A, Wang, W, Schmidt, M, Larcher, L, Segovia, JC, Yáñez, RM, Alberquilla, O, Diez, B, Fernández-García, M, García-García, L, Ramírez, M, Galy, A, Lefrere, F, Cavazzana, M, Leblanc, T, de Andoin, NG, López-Almaraz, R, Catala, A, Barquinero, J, Rodríguez-Perales, S, Rao, G, Surrallés, J, Soulier, J, Díaz-de-Heredia, C, Schwartz, JD, Sevilla, J, Bueren, JA. Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials. LANCET. 2024; 404(10471)DOI:10.1016/S0140-6736(24)01880-4. PMID:39642902. IF:88.500(Q1/1D).
20/12/2024 Effectiveness of an Exercise and Educational-Based Prehabilitation Program in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy (PREOptimize) on Functional Outcomes: A Randomized Controlled Trial
Casanovas-alvarez, A, Estanyol, B, Ciendones, M, Padròs, J, Cuartero, J, Barnadas, A, García-Valdecasas, B, González-Colom, R, Sebio-García, R, Masià, J. Effectiveness of an Exercise and Educational-Based Prehabilitation Program in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy (PREOptimize) on Functional Outcomes: A Randomized Controlled Trial. PHYSICAL THERAPY. 2024; 104(12)DOI:10.1093/ptj/pzae151. PMID:39423256. IF:3.300(Q1/1D).
19/12/2024 Guillain-Barre syndrome
Leonhard, SE, Papri, N, Querol, L, Rinaldi, S, Shahrizaila, N, Jacobs, BC. Guillain-Barre syndrome. Nature Reviews Disease Primers. 2024; 10(1)DOI:10.1038/s41572-024-00580-4. PMID:39702645. IF:60.600(Q1/1D).
19/12/2024 Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024)
Rodríguez-Jorge, F, Fernández-Velasco, JI, Villarrubia, N, Gracia-Gil, J, Fernández, E, Meca-Lallana, V, Díaz-Pérez, C, de la Maza, SS, Pacheco, EM, Quiroga, A, Ramió-Torrentà, L, Martínez-Yélamos, S, Bau, L, Monreal, E, López-Real, A, Rodero-Romero, A, Borrega, L, Díaz, S, Eguía, P, Espiño, M, Chico-García, JL, Barrero, FJ, Martínez-Ginés, ML, García-Domínguez, JM, de la Fuente, S, Moreno, I, Sainz-Amo, R, Mañé-Martínez, MA, Caminero, A, Castellanos-Pinedo, F, López, AG, Labiano-Fontcuberta, A, Ayuso, L, Abreu, R, Hernández, MA, Meca-Lallana, J, Martín-Aguilar, L, Garcia, AM, Masjuan, J, Costa-Frossard, L, Villar, LM. Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis (vol 15, 1480676, 2024). Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1535051. PMID:39749346. IF:5.900(Q1/2D).
18/12/2024 Myocardial Injury in Patients with Hip Fracture A HIP ATTACK Randomized Trial Substudy
Borges, FK, Guerra-Farfan, E, Bhandari, M, Patel, A, Slobogean, G, Feibel, RJ, Sancheti, PK, Tiboni, ME, Balaguer-Castro, M, Tandon, V, Tomas-Hernandez, J, Sigamani, A, Sigamani, A, Szczeklik, W, Mcmahon, SJ, Sleczka, P, Ramokgopa, MT, Adinaryanan, S, Umer, M, Jenkinson, RJ, Lawendy, A, Popova, E, Nur, AN, Wang, CY, Vizcaychipi, M, Biccard, BM, Ofori, S, Spence, J, Duceppe, E, Marcucci, M, Harvey, V, Balasubramanian, K, Vincent, J, Tonelli, AC, Devereaux, PJ, HIP ATTACK Investigators. Myocardial Injury in Patients with Hip Fracture A HIP ATTACK Randomized Trial Substudy. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME. 2024; 106(24)DOI:10.2106/JBJS.23.01459. PMID:39052767. IF:4.300(Q1/1D).
17/12/2024 First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
Piedra, A, Martínez-Recio, S, Hernández, A, Morán, T, Arriola, E, Recuero-Borau, J, Cobo, M, Cordeiro, P, Mosquera, J, Fernández, M, García-Campelo, R, Calles, A, Alvarez, R, Zapata-García, M, Isla, D, Callejo, A, Iranzo, P, Serra-López, J, Barba, A, Sullivan, I, Felip, E, Majem, M. First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study. Frontiers in Oncology. 2024; 14DOI:10.3389/fonc.2024.1510278. PMID:39741981. IF:3.300(Q2/4D).
17/12/2024 Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression
Temprano-Sagrera, G, Peypoch, O, Soto, B, Dilmé, J, Juscafresa, LC, Davtian, D, Estadella, MD, Nieto, L, Brown, A, Escudero, JR, Viñuela, A, Camacho, M, Sabater-Lleal, M. Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression. Journal of the American Heart Association. 2024; 13(24)DOI:10.1161/JAHA.124.036082. PMID:39655704. IF:5.300(Q1/2D).
16/12/2024 International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy ( vol 11 , 70 , 2024)
Zeng, GH, Zhong, W, Mazzon, G, Zhu, W, Lahme, S, Khadgi, S, Desai, J, Agrawal, M, Schulsinger, D, Gupta, M, Montanari, E, Martinez, JML, Almousawi, S, Malonzo, VEF, Sriprasad, S, Durutovic, O, Arumuham, V, Ferretti, S, Kamal, W, Xu, KW, Cheng, F, Gao, XF, Cheng, JW, Somani, B, Duvdevani, M, Git, KA, Seitz, C, Bernardo, N, Ibrahim, TAA, Aquino, A, Yasui, T, Fiori, C, Knoll, T, Papatsoris, A, Gadzhiev, N, Zhanbyrbekuly, U, Angerri, O, Ramos, HL, Saltirov, I, Moussa, M, Giusti, G, Vicentini, F, Suarez, EB, Pearle, M, Preminger, GM, Wu, QH, Chai, CA, Ghani, K, Maroccolo, M, Brehmer, M, Osther, PJ, Zawadzki, M, Tursunkulov, A, Kytaibekovich, MN, Abuvohidov, AA, Lara, CAR, Noori, Z, Zanetti, SP, Shrestha, S, de la Rosette, J, Denstedt, J, Ye, ZQ, Sarica, K, Choong, S. International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy ( vol 11 , 70 , 2024). Military Medical Research. 2024; 11(1)DOI:10.1186/s40779-024-00579-8. PMID:39676164. IF:22.900(Q1/1D).
15/12/2024 Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection
Díaz-Pérez, A, Lope-Piedrafita, S, Pérez, B, Vázquez-Sufuentes, P, Rodriguez-Garcia, M, Briones, AM, Navarro, X, Penas, C, Jiménez-Altayó, F. Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection. LIFE SCIENCES. 2024; 359DOI:10.1016/j.lfs.2024.123247. PMID:39547431. IF:5.100(Q1/2D).
13/12/2024 A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience
Filippi-Arriaga, F, Molina, P, Delgado-Espinoza, CE, Antonijoan, R. A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience. MEDICINA CLINICA. 2024; 163(11)DOI:10.1016/j.medcli.2024.06.001. PMID:39043476. IF:2.100(Q2/3D).
13/12/2024 Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol
Fernandez-Camins, B, Vlacho, B, Canudas, A, Ortega, M, Granado-Casas, M, Perera-LLuna, A, Boluda-Sanson, A, El-Khattabi-Ofkir, Y, Franch-Nadal, J, Mauricio, D. Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol. BMJ Open. 2024; 14(12)DOI:10.1136/bmjopen-2023-083825. PMID:39675821. IF:2.300(Q2/3D).
10/12/2024 Endoscopic versus robotic myotomy for treatment of achalasia (ERMA trial): protocol for a randomized clinical multicentre trial
Garsot, E, Company-Se, G, Uchima, H, Marin, I, Viciano, M, Clavell, A, Ananin, SF, Miró, M, Guarner, C, Gornals, J, Bettonica, C, Momblán, D, Esparrach, MGF, Araujo, I, Nescolarde, L. Endoscopic versus robotic myotomy for treatment of achalasia (ERMA trial): protocol for a randomized clinical multicentre trial. BJS Open. 2024; 8(6)DOI:10.1093/bjsopen/zrae130. PMID:39658017. IF:4.500(Q1/1D).
09/12/2024 Impact of Optimal Procedural Result After Transcatheter Edge-to-Edge Tricuspid Valve Repair Results From TRI-SPA Registry
Echarte-Morales, J, Guerreiro, CE, Freixa, X, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, MN, Nombela-Franco, L, Pascual, I, Benito-González, T, Perez, R, Gómez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Barreiro-Perez, M, Sanchis, L, Caneiro-Queija, B, Li, CH, del Trigo, M, Martínez-Carmona, JD, Mesa, D, Jiménez, P, Avanzas, P, Cepas-Guillén, P, Estévez-Loureiro, R. Impact of Optimal Procedural Result After Transcatheter Edge-to-Edge Tricuspid Valve Repair Results From TRI-SPA Registry. JACC-Cardiovascular Interventions. 2024; 17(23)DOI:10.1016/j.jcin.2024.08.003. PMID:39520435. IF:11.400(Q1/1D).
06/12/2024 Atherogenic circulating lipoproteins in ischemic stroke
Benitez, S, Puig, N, Camps-Renom, P, Sánchez-Quesada, JL. Atherogenic circulating lipoproteins in ischemic stroke. Frontiers in Cardiovascular Medicine. 2024; 11DOI:10.3389/fcvm.2024.1470364. PMID:39713216. IF:2.900(Q2/4D).
05/12/2024 Safety in patients with latent tuberculosis who received concomitant anti-tuberculosis medications: analysis of 11 studies of guselkumab in psoriatic disease
Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londono, A, Lebwohl, M, Nash, P. Safety in patients with latent tuberculosis who received concomitant anti-tuberculosis medications: analysis of 11 studies of guselkumab in psoriatic disease. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae360.098. PMID:. IF:9.600(Q1/1D).
05/12/2024 Effectiveness of biologics in clinical practice: Month 12 absolute psoriasis area and severity index outcomes from an international observational Psoriasis Study of Health Outcomes
Maul, JT, Bonnekoh, B, Puig, L, McKenzie, R, Lampropoulou, A, Martimianaki, G, Fotiou, K, Pinter, A, Akiror, C. Effectiveness of biologics in clinical practice: Month 12 absolute psoriasis area and severity index outcomes from an international observational Psoriasis Study of Health Outcomes. BRITISH JOURNAL OF DERMATOLOGY. 2024; 191DOI:10.1093/bjd/ljae360.093. PMID:. IF:9.600(Q1/1D).
03/12/2024 Cardiogenic Shock Complicating Takotsubo Syndrome: Sex-Related Differences
Tomasino, M, Núñez-Gil, IJ, Martínez-Selles, M, Vedia, O, Corbí-Pascual, M, Salamanca, J, Blanco-Ponce, E, Cordón, CF, Almendro-Delia, M, Pérez-Castellanos, A, Martín-García, A, Vila-Sanjuán, S, Vazirani, R, Duran-Cambra, A, Becerra-Muñoz, VM, Guillén-Marzo, M, Uribarri, A. Cardiogenic Shock Complicating Takotsubo Syndrome: Sex-Related Differences. Journal of the American Heart Association. 2024; 13(23)DOI:10.1161/JAHA.124.036800. PMID:39611302. IF:5.300(Q1/2D).